- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ScinoPharm Taiwan Ltd (1789)
Assess today's live ScinoPharm Taiwan Ltd (1789) share price, performance and insights using our live Taiwan: 1789 stock exchange data.
Analyse the historical data and ScinoPharm Taiwan Ltd share price performance charts on this page. Our technical summary section provides analysis on SPT share price buy/sell indicators using real-time data (or discuss the SPT (1789) stock price today with other investors in the SPT TW share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TW 1789 share price (ISIN: TW0001789006) to enhance your trading decisions with our free investment tools and resources.
What Is the ScinoPharm Taiwan Ltd Share Price Today?
The SPT share price today is 23.60.
What Is the Stock Symbol for ScinoPharm Taiwan Ltd
The stock symbol (or 'ticker') for ScinoPharm Taiwan Ltd is "1789."
What Stock Exchange Does ScinoPharm Taiwan Ltd Trade On?
ScinoPharm Taiwan Ltd is listed and trades on the Taiwan stock exchange.
Is ScinoPharm Taiwan Ltd a Good Stock to Buy?
Determining whether ScinoPharm Taiwan Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and ScinoPharm Taiwan Ltd share price performance charts on this page. Our technical summary section provides analysis on SPT share price buy/sell indicators using real-time data (or discuss the SPT (1789) stock price today with other investors in the SPT TW share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TW 1789 share price (ISIN: TW0001789006) to enhance your trading decisions with our free investment tools and resources.
What Is the ScinoPharm Taiwan Ltd Share Price Today?
The SPT share price today is 23.60.
What Is the Stock Symbol for ScinoPharm Taiwan Ltd
The stock symbol (or 'ticker') for ScinoPharm Taiwan Ltd is "1789."
What Stock Exchange Does ScinoPharm Taiwan Ltd Trade On?
ScinoPharm Taiwan Ltd is listed and trades on the Taiwan stock exchange.
Is ScinoPharm Taiwan Ltd a Good Stock to Buy?
Determining whether ScinoPharm Taiwan Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Taiwan
Currency in TWD
23.60
0.00(0.00%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.30
25.25
52 wk Range
16.25
29.10
1789 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.3025.25
52 wk Range
16.2529.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1789 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
18.00
Downside
-23.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
SPT Company Profile
ScinoPharm Taiwan, Ltd., together with its subsidiaries, research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, the America, and internationally. The company provides small molecular drugs, protein drugs, complex natural molecules and derivatives, synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; outsourcing services. It offers CDMO services, such as contract analytical testing services, sterile injectables contract manufacturing, small molecules CDMO service, peptide CDMO service, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates, as well as develops peptide synthesis technologies. In addition, the company develops and manufactures western medicines and other chemical materials, albumin and oligonucleotide medicines, and injections, as well as provides biological technology services, technical, and intellectual property rights related services. ScinoPharm Taiwan, Ltd. was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
Compare 1789 to Peers and Sector
Metrics to compare | 1789 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1789PeersSector | |
|---|---|---|---|---|
P/E Ratio | 96.7x | 38.1x | −0.6x | |
PEG Ratio | −1.84 | 0.79 | 0.00 | |
Price/Book | 1.7x | 3.8x | 2.6x | |
Price / LTM Sales | 5.8x | 6.8x | 3.3x | |
Upside (Analyst Target) | −23.7% | 13.9% | 45.0% | |
Fair Value Upside | Unlock | 3.1% | 6.5% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 18.00
(-23.73% Downside)
Earnings
Latest Release
Nov 03, 2025
EPS / Forecast
0.10 / 0.10
Revenue / Forecast
800.00M / 800.00M
FAQ
What Is the SPT (1789) Share Price Today?
The live SPT share price today is 23.60
What Stock Exchange Does SPT (1789) Trade On?
SPT is listed and trades on the Taiwan Stock Exchange.
What Is the Ticker (Stock Symbol) for SPT?
The stock symbol (also called a 'ticker') for SPT is "1789."
Does SPT Pay Dividends? What’s The Current 1789 Dividend Yield?
Yes, 1789 Pays Dividends to its Shareholders. The current SPT dividend yield is 1.45%.
What Is the Current SPT Market Cap?
As of today, SPT market capitalisation is 18.66B.
What Is SPT's (1789) Earnings Per Share (TTM)?
The SPT EPS is currently 0.24 (Trailing Twelve Months).
When Is the Next SPT Earnings Date?
SPT's next earnings report will be released on 04 Mar 2026.
Is 1789 a Buy or Sell From a Technical Analyst Perspective?
Based on today's SPT moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has SPT Stock Split?
SPT has split 6 times. (See the 1789 stock split history page for full effective split date and price information.)
How Many Employees Does SPT Have?
SPT has 540 employees.
What is the current trading status of SPT (1789)?
As of 04 Feb 2026, SPT (1789) is trading at a price of 23.60, with a previous close of 21.00. The stock has fluctuated within a day range of 23.30 to 25.25, while its 52-week range spans from 16.25 to 29.10.
What Is SPT (1789) Price Target According to Analysts?
The average 12-month price target for SPT is TWD18.00, with a high estimate of TWD18 and a low estimate of TWD18. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -23.73% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.